Global Blood (GBT) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 39 253 sessions, October 4, 2021 to October 4, 2022
- Largest daily move
- +41.4% close of August 4, 2022
- 1-year change
- +162.2% closing prices, October 4, 2021 to October 4, 2022
- 1-month change
- +1% closing prices, September 2, 2022 to October 4, 2022
Company Description
Global Blood (NASDAQ: GBT) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $4.6B.
GBT has gained 162.2% over the past year. The last closing price was $68.49.
This page collects what Stock Titan holds for GBT, including price data and latest news.
Stock Performance
Global Blood (GBT) closed at $68.49 on October 4, 2022. Over the past 12 months, the price has gained 162.2%.
GBT Metrics & Rankings
Price returns through October 4, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Global Blood has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include conferences, acquisition, earnings. View all GBT news →
SEC Filings
GBT Company Profile & Sector Positioning
Global Blood (GBT) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing GBT often look at related companies in the same sector, including PTC Therapeutics, Inc. (PTCT), CRISPR Therapeutics AG (CRSP), Jyong Biotech Ltd. (MENS), Arcellx, Inc. (ACLX), and Vaxcyte, Inc. (PCVX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GBT's relative position within its industry.